Trevena terminates CEO, COO/CFO, and CMO without cause; all continue in acting roles

TREVENA INC

CEO Carrie Bourdow, COO/CFO Barry Shin, and CMO Mark Demitrack terminated Oct 5, 2024 as cost-cutting measure.
Bourdow remains Chairman and Acting CEO; Shin as Acting COO/CFO; Demitrack as Acting CMO.
Bourdow severance: $877,500 salary, $526,500 bonus, $321,078.69 pro rata bonus, plus health payment.
Equity vesting accelerated for 12 months of shares; additional benefits if change of control occurs.
Shin and Demitrack signed consulting agreements for continued advisory at prior compensation rates.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change (interim)

Barry Shin

Executive Vice President, Chief Operating Officer and Chief Financial Officer

TREVENA INC

Effective: 2024-10-05
Filed: October 10, 2024, 7:59 PM ET

approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer

Role change (interim)

Carrie L. Bourdow

President and Chief Executive Officer

TREVENA INC

Effective: 2024-10-05
Filed: October 10, 2024, 7:59 PM ET

approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer

Role change (interim)

Mark A. Demitrack

Senior Vice President and Chief Medical Officer

TREVENA INC

Effective: 2024-10-05
Filed: October 10, 2024, 7:59 PM ET

approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Barry Shin was terminated as Executive Vice President, Chief Operating Officer and Chief Financial Officer at TREVENA INC.

Action: terminated
Role: Executive Vice President, Chief Operating Officer and Chief Financial Officer

Exact text from the filing

approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Carrie L. Bourdow was terminated as President and Chief Executive Officer at TREVENA INC.

Action: terminated
Role: President and Chief Executive Officer

Exact text from the filing

approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark A. Demitrack was terminated as Senior Vice President and Chief Medical Officer at TREVENA INC.

Action: terminated
Role: Senior Vice President and Chief Medical Officer

Exact text from the filing

approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer

View on SEC.gov

Source: SEC EDGAR

accession 0001104659-24-107736

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.